Multiple Myeloma
📧 Sign up to get email alerts when something new happens for Multiple Myeloma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2012-06-06Clinical Trial Update: Peripheral Blood Lymphocyte Therapy to Prevent Lymphoproliferative Disorders Caused by Epstein-Barr Virus in Patients Who Have Undergone Transplantation [Phase 2]
Phase 2 trial of peripheral blood lymphocyte therapy using EBV-specific cytotoxic T cells to prevent EBV-related lymphoproliferative disorde…
-
CLINICAL_TRIALS trial_result · 2012-06-06Clinical Trial Update: Melphalan Followed by Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma [Phase 3]
Phase 3 trial evaluating melphalan followed by peripheral stem cell transplantation in patients with multiple myeloma has completed.
-
CLINICAL_TRIALS trial_result · 2012-06-06Clinical Trial Update: Peripheral Stem Cell Transplantation in Treating Patients With Breast Cancer or Hematologic Cancer [Phase 1, Phase 2]
This clinical trial update reports the completion of a phase 1/2 study evaluating peripheral stem cell transplantation in patients with brea…
-
CLINICAL_TRIALS research · 2012-06-04Clinical Trial Update: Autologous Bone Marrow Transplantation (BMT) Compared With Allogeneic BMT in Multiple Myeloma [Phase 2, Phase 3]
This entry reports a Phase 2/Phase 3 clinical trial comparing autologous and allogeneic bone marrow transplantation in multiple myeloma; cur…
-
CLINICAL_TRIALS trial_result · 2012-06-01Clinical Trial Update: Bone Marrow and Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer [Phase 1]
Phase 1 clinical trial update on bone marrow and peripheral stem cell transplantation for patients with hematologic cancers; the study statu…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2012-05-30Clinical Trial Update: Tocladesine in Treating Patients With Recurrent or Refractory Multiple Myeloma [Phase 2]
A Phase 2 clinical trial evaluating tocladesine for recurrent or refractory multiple myeloma has completed.
-
CLINICAL_TRIALS research · 2012-05-30Clinical Trial Update: Third-line Therapy of Multiple Myeloma a Prospective Phase I /II Trial [Phase 1, Phase 2]
A prospective Phase 1/2 clinical trial evaluating a third-line therapy for multiple myeloma, sponsored by the University of Regensburg; curr…
-
CLINICAL_TRIALS trial_result · 2012-05-28Clinical Trial Update: Arsenic Trioxide, Thalidomide, Dexamethasone, and Ascorbic Acid in Treating Patients With Relapsed or Refractory Multiple Myeloma [Phase 2]
A Phase 2 trial of a combination including arsenic trioxide, thalidomide, dexamethasone, and ascorbic acid for relapsed or refractory multip…
-
CLINICAL_TRIALS trial_result · 2012-05-28Clinical Trial Update: G-CSF-Treated Donor Bone Marrow Transplant in Treating Patients With Hematologic Disorders [NA]
Clinical trial update for a study evaluating G-CSF–treated donor bone marrow transplant in hematologic disorders; the trial (NCT00253552) is…
-
CLINICAL_TRIALS trial_result · 2012-05-17Clinical Trial Update: Cellular Therapy With Cord Blood Cells [Phase 2]
Phase 2 trial evaluating cord blood cell–based cellular therapy in patients with multiple myeloma, leukemia, or lymphoma. Results were poste…
-
CLINICAL_TRIALS research · 2012-05-16Clinical Trial Update: A Study Evaluating Hypotension and Autonomic Nervous System Dysfunction in Multiple Myeloma (MM) Patients
An ongoing clinical trial in patients with multiple myeloma is evaluating hypotension and autonomic nervous system dysfunction; the current …
-
CLINICAL_TRIALS trial_result · 2012-05-11Clinical Trial Update: A Study to Compare MPR With MP in Newly Diagnosed Multiple Myeloma Subjects 65 Years Old or Older. [Phase 3]
Phase 3 trial update comparing MPR (melphalan-prednisone-thalidomide) with MP (melphalan-prednisone) in newly diagnosed multiple myeloma pat…
-
CLINICAL_TRIALS withdrawal · 2012-05-11Clinical Trial Update: Study of Vorinostat With Doxil and Bortezomib for Patients With Relapsed/Refractory Multiple Myeloma [Phase 2]
A Phase 2 trial evaluating the combination of vorinostat (Zolinza) with Doxil and bortezomib for relapsed/refractory multiple myeloma has be…
-
CLINICAL_TRIALS trial_result · 2012-05-10Clinical Trial Update: A Study of Peripheral Blood Progenitor Cells Mobilisation (PBPC) With VTP195183 Plus Granulocyte-Colony Stimulating Factor (G-CSF) Compared to Mobilisation With G-CSF Alone [Phase 1, Phase 2]
A Phase 1/2 trial compares mobilisation of peripheral blood progenitor cells using VTP195183 plus G-CSF versus G-CSF alone in patients with …
-
CLINICAL_TRIALS trial_result · 2012-04-26Clinical Trial Update: Study of Velcade® and Bone Formation in Patients With Relapsed/Refractory Multiple Myeloma [Phase 2]
Phase 2 study evaluating Velcade (bortezomib) in relapsed/refractory multiple myeloma with bone-formation outcomes; the trial was terminated…
-
CLINICAL_TRIALS trial_result · 2012-04-19Clinical Trial Update: Study of KIR-Ligand Mismatched Haplo-Identical Natural Killer Cells Transfused Before Autologous Stem Cell Transplant [Phase 1]
The study evaluated transfusing KIR-ligand mismatched haplo-identical natural killer (NK) cells before autologous stem cell transplantation …
-
CLINICAL_TRIALS trial_result · 2012-04-05Clinical Trial Update: Alternative Schedule of Velcade/Dexamethasone Plus Doxil for Patients With Multiple Myeloma [Phase 2]
Phase 2 trial evaluating an alternative schedule of Velcade (bortezomib), dexamethasone, and liposomal doxorubicin (Doxil) in multiple myelo…
-
CLINICAL_TRIALS withdrawal · 2012-03-26Clinical Trial Update: A Study of GSK2110183 in Subjects With Proteasome Inhibitor Refractory Multiple Myeloma [Phase 2]
A Phase 2 trial of GSK2110183 in proteasome inhibitor refractory multiple myeloma has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2012-03-21Clinical Trial Update: Health-Related Quality of Life (QOL), Physical and Respiratory Function in Patients With Myeloma Affecting the Spine
This document reports the completed clinical trial evaluating health-related quality of life, physical function, and respiratory function in…
-
CLINICAL_TRIALS trial_result · 2012-03-16Clinical Trial Update: CD8+ T Cell Depletion for GVHD Prophylaxis After Peripheral Blood Stem Cell Transplantation [NA]
This clinical trial update reports on a study evaluating CD8+ T cell depletion as prophylaxis against graft-versus-host disease after periph…
-
CLINICAL_TRIALS research · 2012-03-15Clinical Trial Update: Telomerase Activity as a Marker For Mobilization Quality
This clinical trial update discusses telomerase activity as a biomarker to assess mobilization quality in patients with lymphoma or multiple…
-
CLINICAL_TRIALS trial_result · 2012-03-14Clinical Trial Update: A Multicentre, Single-arm, Open-label Safety Study of Lenalidomide Plus Dexamethasone in Previously Treated Subjects With Multiple Myeloma [Phase 3]
A multicenter, single-arm, open-label safety study evaluating lenalidomide plus dexamethasone in patients with previously treated multiple m…
-
CLINICAL_TRIALS trial_result · 2012-03-08Clinical Trial Update: T-Cell-Depleted Allogeneic Stem Cell Transplantation After Immunoablative Induction Chemotherapy and Reduced-Intensity Transplantation Conditioning in Treating Patients With Hematologic Malignancies [Phase 1]
Phase 1 trial assessing T-cell-depleted allogeneic stem cell transplantation after immunoablative induction chemotherapy and reduced-intensi…
-
CLINICAL_TRIALS withdrawal · 2012-02-23Clinical Trial Update: Safety Study of Anti-Programmed Death-Ligand 1 in Hematologic Malignancy [Phase 1]
Phase 1 safety study of a PD-L1 inhibitor sponsored by Bristol-Myers Squibb has been withdrawn. The study targeted hematologic malignancies …
-
CLINICAL_TRIALS research · 2012-02-15Clinical Trial Update: Iberoamerican Protocol With Thalidomide in Patients With Symptomatic Newly Diagnosed Multiple Myeloma Over 65 Years [Phase 3]
Phase 3 trial update on thalidomide for symptomatic newly diagnosed multiple myeloma in patients over 65.